FDA Inspection 1109095 — Emergent BioSolutions Canada Inc.
The FDA completed an inspection of Emergent BioSolutions Canada Inc. on Sep 13, 2019 in Winnipeg. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 13, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Winnipeg (Canada)